New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Sabinsa granted U.S. patent for selenium dipeptides

Sabinsa granted U.S. patent for selenium dipeptides
This patent represents the 72nd in Sabinsa Corp.’s global patent portfolio.

The US Patent Office has awarded Sabinsa Corporation a patent (US 8193156) for the preparatory route for dipeptides incorporating selenoamino acids.

The patent is titled “Dipeptides incorporating selenoamino acids with enhanced bioavailability--synthesis, pharmaceutical and cosmeceutical applications thereof,” is specific to the preparatory route for L-Selenomethionine peptide having not only excellent vascular endothelial growth factor (VEGF) and anti-5-alpha reductase activity, which are important properties for maintaining perfect homeostasis for “hair care”, but also increased water solubility and bioavailability, enhancing their benefits in hair care industry.

Dr. Anurag Pande, Sabinsa’s Vice President, Scientific Affairs, said “this discovery by the Sabinsa research team creates a lot of opportunity given the product’s capabilities to prevent and reduce hair loss, maintaining perfect homeostasis for hair care.”

This patent represents the 72nd in Sabinsa Corporation’s global patent portfolio.

 

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish